Science Market Update

UCSF Granted $20M for HIV Research Institute

Posted by Laura Braden on Mon, Jan 11, 2016

Since HIV/AIDS emerged as a global health problem in the 1980's, researchers have been diligently working to create new treatments and vaccines for the disease. Currently, there is no cure for the disease, and treatments can only suppress it. Because of its severity and broad reach, scientists around the world receive substantial funding each year to study this virus in order to gain a more thorough understanding and better combat it. Now, thanks to an award from the Foundation for AIDS Research (amfAR), researchers at the University of California, San Francisco will be able to study the virus in a new $20 million institute, located on the Mission Bay campus, for the next five years.
Read More

Tags: CA, University of California San Francisco, HIV, AIDS Research, Southwest, San Francisco, SFVS, Biotechnology Vendor Showcase, UCSF, UCSF Mission Bay, New research center, 2016

NY Scientists Awarded $3.1M for HIV Vaccine Research

Posted by Laura Braden on Tue, Nov 10, 2015

Since its emergence in the 1980's, HIV/AIDS has been a prominent point of research for life scientists around the world. With no current cure or vaccine available, scientists receive substantial amounts of funding to study this virus to gain a better understanding of it as well as to produce a vaccine that will combat the virus better than current treatments do, which can only slow and control the virus, but not cure it.

Read More

Tags: Northeast, HIV, infectious diseases, New York, Rochester, BioResearch Product Faire Event, NY, 2016, University of Rochester, URoch, HIV Vaccine, B Cells

Rockefeller Researchers Make Advances with HIV Vaccine

Posted by Robert Larkin on Tue, Jul 07, 2015

In collaboration with researchers at The Scripps Research Institute, Weill Cornell Medical College, and other institutions, scientists at Rockefeller University are working to harness the natural potential of the human immune system to develop a series of sequential vaccinations against the HIV virus. 

Read More

Tags: Rockefeller University, Bioresearch, HIV, Bioscience, infectious diseases, New York, 2015, disease research, RockU, BioResearch Product Faire Event, NY, NIH, Northeast Region, AIDS vaccine research, life science tradeshows

OHSU Isn't "Monkeying" Around, Gets $7M+ for HIV/AIDS

Posted by Robert Larkin on Wed, Apr 22, 2015

HIV and AIDS have been a conspicuous concern worldwide for several decades now; research into its treatment regularly gains national attention and benefits from billions of dollars in research funding. What many people may not realize, however, is that simian immunodeficiency virus, (or SIV, a nonhuman primate form of HIV that causes AIDS in monkeys) may hold the keys to unlocking the mysteries of how HIV can be treated in humans.

Read More

Tags: HIV, AIDS Research, Oregon Health and Science University, Oregon, 2015, BioResearch Product Faire Event, Research Funding, NIH, OHSU, NIH grants, Bioreseach

Emory Bioresearchers Learn Why Many HIV Vaccines Cause More Infections Than They Heal

Posted by Laura Braden on Tue, Feb 24, 2015

Since the Human Immunodeficiany Virus (HIV) emerged as a global health problem, researchers have been diligently working to discover new vaccines to treat the disease. However, many of the current treatments for HIV tend to cause more infections and further damage instead of working as a cure. 

Read More

Tags: Emory University, HIV, vaccine research, Southern, 2015, Emory, BioResearch Product Faire Event, Atlanta, GA, AIDS vaccine research, Yerkes National Primate Research Center

UMN Bioscientists Explore HIV Immunity

Posted by Sam Asher on Thu, Nov 27, 2014

The human immunodeficiency virus, known more commonly as HIV, is still at large today. With no known cure, the most researchers have been able to do is mitigate the effects of the virus. However, there are certain people who, despite being exposed to HIV, simply do not get infected. A team of biologists at the University of Minnesota, Twin Cities set out to find whether genetic differences play a role in this “immunity” to HIV.

Read More

Tags: HIV, University of Minnesota Twin Cities, 2015, UMinn

HIV Stung by Bee Toxin at WUSTL

Posted by Sam Asher on Thu, Mar 14, 2013

In an effort to better combat the infamous human immunodeficiency virus (HIV), researchers at Washington University in St. Louis have developed a solution that carries quite a sting. Utilizing a toxin found in bee venom, they have developed a nanoparticle that is quite effective at destroying the virus.

Read More

Tags: 2014, Midwest, 2013, Washington University, Missouri, WashU, WUSTL, nanoparticle, HIV, bee venom, melittin, BioResearch Product Faire Event, MO, St Louis, laboratory equipment, laboratory equipment suppliers

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!